Pitcairn’s Cytosorbents Corp CTSO Stock Holding History

Pitcairn’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11,380	Closed	-$147K	–	476
2018 Q3	$147K	Buy	+11,380	New	+$143K	0.02%	521

Other funds holding CTSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

USAA

United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Pitcairn's CTSO Position: Q4 2018 in Review

Pitcairn sold out of Cytosorbents Corp (CTSO) in Q4 2018, closing a stake of 11,380 shares — an estimated $147K sold.

Pitcairn first reported a position in CTSO in Q3 2018 and held it in 1 quarter. The position peaked at $147K in Q3 2018. 85 funds tracked by Wall St. Rank hold CTSO as of Q4 2018.

Pitcairn reported no remaining Cytosorbents Corp position as of Q4 2018 after selling out during the quarter.
Pitcairn sold 11,380 Cytosorbents Corp shares in Q4 2018, an estimated $147K.
Pitcairn first reported a position in Cytosorbents Corp in Q3 2018 and held it in 1 quarter.
Pitcairn's Cytosorbents Corp position peaked at $147K in Q3 2018.
85 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2018.

Based on Pitcairn's 13F filing for Q4 2018, filed 12 Feb 2019.